---
title: "Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293395375.md"
description: "The NMPA has approved the supplemental application for the use of Toripalimab in combination with chemotherapy as a perioperative treatment for resectable stage Ⅱ-Ⅲ NSCLC. This decision allows for the treatment to be used in patients with these specific stages of non-small cell lung cancer."
datetime: "2026-07-21T23:12:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293395375.md)
  - [en](https://longbridge.com/en/news/293395375.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293395375.md)
generator: "portal-rs"
---

# Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

The NMPA has approved the supplemental application for the use of Toripalimab in combination with chemotherapy as a perioperative treatment for resectable stage Ⅱ-Ⅲ NSCLC. This decision allows for the treatment to be used in patients with these specific stages of non-small cell lung cancer.

### Related Stocks

- [01877.HK](https://longbridge.com/en/quote/01877.HK.md)
- [688180.CN](https://longbridge.com/en/quote/688180.CN.md)

## Related News & Research

- [Junshi Biosciences Discloses Planned Stake Reduction by Key A-Share Investor](https://longbridge.com/en/news/297448755.md)
- [Junshi Biosciences terminates 2026 A-share employee stock ownership scheme](https://longbridge.com/en/news/297027904.md)
- [06:05 ETKarmanos Now Offers FDA-Approved Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancer](https://longbridge.com/en/news/297497971.md)
- [Alpha Tau completes enrollment in 48-patient IMPACT pancreatic cancer Alpha DaRT pilot study](https://longbridge.com/en/news/297513505.md)
- [Jazz says FDA approves Ziihera combos for first-line HER2+ advanced gastroesophageal cancer](https://longbridge.com/en/news/297497068.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**